Bumrungrad Hospital Public Company Limited (F:BZ7A) — Market Cap & Net Worth
Market Cap & Net Worth: Bumrungrad Hospital Public Company Limited (BZ7A)
Bumrungrad Hospital Public Company Limited (F:BZ7A) has a market capitalization of $54.86K (€46.92K) as of August 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #31480 globally and #2828 in its home market, demonstrating a 8.26% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bumrungrad Hospital Public Company Limited's stock price €4.98 by its total outstanding shares 9422 (9.42K). See BZ7A capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Bumrungrad Hospital Public Company Limited Market Cap History: 2015 to 2026
Bumrungrad Hospital Public Company Limited's market capitalization history from 2015 to 2026. Data shows growth from $20.93 to $54.86K (107.42% CAGR).
Bumrungrad Hospital Public Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bumrungrad Hospital Public Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Bumrungrad Hospital Public Company Limited's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Bumrungrad Hospital Public Company Limited's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $33.05 | $17.91 Billion | $3.63 Billion | 0.00x | 0.00x |
| 2017 | $61.69 | $18.35 Billion | $3.94 Billion | 0.00x | 0.00x |
| 2018 | $122.27 | $18.33 Billion | $4.15 Billion | 0.00x | 0.00x |
| 2019 | $229.12 | $18.47 Billion | $3.75 Billion | 0.00x | 0.00x |
| 2020 | $651.00 | $12.36 Billion | $1.20 Billion | 0.00x | 0.00x |
| 2021 | $2.55K | $12.46 Billion | $1.22 Billion | 0.00x | 0.00x |
| 2022 | $9.17K | $20.72 Billion | $4.94 Billion | 0.00x | 0.00x |
| 2023 | $19.00K | $25.38 Billion | $7.01 Billion | 0.00x | 0.00x |
| 2024 | $60.58K | $25.72 Billion | $7.77 Billion | 0.00x | 0.00x |
| 2025 | $46.26K | $25.22 Billion | $7.51 Billion | 0.00x | 0.00x |
Competitor Companies of BZ7A by Market Capitalization
Companies near Bumrungrad Hospital Public Company Limited in the global market cap rankings as of August 1, 2026.
Key companies related to Bumrungrad Hospital Public Company Limited by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #905 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #994 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1356 globally with a market cap of $18.52 Billion USD ( RM73.78 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $402.59 |
| #905 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €44.52 |
| #994 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1356 | IHH Healthcare Bhd | KLSE:5225 | $18.52 Billion | RM8.35 |
Bumrungrad Hospital Public Company Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Bumrungrad Hospital Public Company Limited's market cap moved from $20.93 to $ 54.86K, with a yearly change of 107.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €54.86K | +18.57% |
| 2025 | €46.26K | -23.64% |
| 2024 | €60.58K | +218.80% |
| 2023 | €19.00K | +107.33% |
| 2022 | €9.17K | +258.82% |
| 2021 | €2.55K | +292.39% |
| 2020 | €651.00 | +184.13% |
| 2019 | €229.12 | +87.39% |
| 2018 | €122.27 | +98.21% |
| 2017 | €61.69 | +86.67% |
| 2016 | €33.05 | +57.89% |
| 2015 | €20.93 | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Bumrungrad Hospital Public Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $54.86K USD |
| MoneyControl | $54.86K USD |
| MarketWatch | $54.86K USD |
| marketcap.company | $54.86K USD |
| Reuters | $54.86K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic,… Read more